Home/Solventum/Michael G. Vale

MG

Michael G. Vale

Board Director

Therapeutic Areas

Wound Care Dental Health Surgical Infection Prevention Biopharmaceutical Processing

Solventum Pipeline

Drug	Indication	Phase
V.A.C.® VERAFLO™ Therapy	Complex Wound Management	Commercial
Acera Restrata® Scaffold	Soft Tissue Regeneration	Commercial Integration
Filtek™ Universal Restorative	Dental Caries	Commercial
HIS AI Coding Engines	Medical Coding Automation	Continuous Development

Leadership Team at Solventum

Bryan C. Hanson

Chair, President & Chief Executive Officer

Wayne M. Fortun

Executive Vice President & Chief Financial Officer

Lead Independent Director

Jeanmarie F. Desmond

EVP & Chief Transformation Officer

View full Solventum profile